Detection of infection by Toxoplasma and Herpes simplex virus 2 among women exposed to abortion in Ninavah province/ Iraq
Article Sidebar
Main Article Content
Abstract
The aims of this study were to find the relationship among the infection of Toxoplasma, herpes simplex virus and abortion at different age groups. For this purpose 127 samples from healthy women were collected in period from February to September 2017 to detected of IgM and IgG for Toxoplasma and Herpes simplex virus2.
The results of the current study showed that Toxoplasmosis was the most common infection with high level of IgM antibodies 11.8%. Herpes simplex 2 virus give positive results for IgM in rate of 6.2% and none of them showed raised IgG level. HSV-II virus infected was the lowest and age group 32-40 years showed the highest rate of infection 12.5%.
Most of the patients experienced two abortions were reported at age group 25-31 years 17% and 4.2% had three abortions. 40% of the patients with Toxoplasmosis experience 2 abortion had cut off >1.25. fifty% with Herpes simplex 2 had cut off value of >1.25 experience one abortions and two abortions respectively.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Robert-Gangneux, F., & Darde, M. L. (2012). Epidemiology of and diagnostic strategies for toxoplasmosis. Clinical microbiology reviews 25(2): 264-296.
[2] Salibay, C. C., Torres, M. S., Salibay, S. P. C., & Nissapatorn, V. (2017). Congenital Toxoplasmosis: The Unknown Disease Burden of Pregnant Women in Southeast Asia. Journal of Pediatric Infectious Diseases
[3] Hajsoleimani, F.; Ataeian, A.; Nourian, A. A.; and Mazloomzadeh, S. (2012). Seroprevalence of Toxoplasma gondii in pregnant women and bioassay of IgM positive cases in Zanjan, Northwest of Iran. Iranian J. Parasitol. 7(2): 82-86
[4] Malarvizhi, A.; Viswanathan, T.; Lavanya, V.; Arul Sheeba, M. S.; and Moorthy, K. (2012). Seroprevalence of Toxoplasma gondii in pregnant women. J. Pub. Health. & Epidemiology. 4(6): 170-177
[5] Montoya JG, Rosso F. (2005). Diagnosis and management of toxoplasmosis.
Clin Perinatol. 32: 705 -726.
[6] Torgerson PR, Mastroiacovo P. (2013) The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 91: 501508.
[7] Oz, H. S. (2017). Fetomaternal and pediatric toxoplasmosis. Journal of pediatric infectious diseases. 12(04): 202-208
[8] Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, Berman SM, Markowitz LE. (2006). Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296: 964-973
[9] Gupta R, Warren T, Wald A. (2007). Genital herpes. Lancet 22: 2127-2137.
[10] Kriebs JM. (2008). Understanding herpes simplex virus: transmission, diagnosis, and considerations in pregnancy management. J Midwifery Womens Health 53: 202-208.
[11] Brown ZA, Benedetti J, Selke S, Ashley R, Watts DH, Corey L. (1996). Asymptomatic maternal shedding of herpes simplex virus at the onset of labor: Relationship to preterm labor. Obstet Gynecol 87(4): 483-488.
[12] Baker DA. (2007). Consequences of herpes simplex virus in pregnancy and their prevention. Curr Opin Infect Dis 20:73-76.
[13] Drueish, M. J., & Aziz, F. M. (2011). Toxoplasmosis: serious disease during pregnancy. Baghdad Science Journal, 8(1), 91-95.
[14] Hasan, A. R. S., Al-Duliami, A. A., Hwaid, A. H., Mageed, W. A., & Fadeel, Z. G. (2013). Seroprevalence of Anti-Herpes Simplex Virus Type2 IgG, IgM Antibodies Among Pregnant Women in Diyala Province. Diyala Journal of Medicine, 5(1), 36-43.
[15] Moniri, R., Baghbani Taheri, F., Sadat, S., & Heidarzadeh, Z. (2015). Prevalence of serum antibodies to TORCH infection in the first trimester of the pregnancy in Kashan, Iran. Iranian Journal of Neonatology IJN 6(1): 8-12.
[16] Mohaghegh, M. A., Kalani, H., Hashemi, M., Hashemi, S., Yazdnezhad, S. K., Hejazi, S. H., & Hashemi, N. (2016). Toxoplasmosis-related risk factors in pregnant women in the North Khorasan province, Iran. Health Sciences, 5(8): 370-374.
[17] Kamal, A. M., Ahmed, A. K., Abdellatif, M. Z., Tawfik, M., & Hassan, E. E. (2015). Seropositivity of toxoplasmosis in pregnant women by ELISA at Minia University Hospital, Egypt. The Korean journal of parasitology, 53(5): 605.
[18] Kalu, E. I., Ojide, C. K., Chuku, A., Chukwuonye, I. I., Agwu, F. E., Nwadike, V. U. & Okafor, G. O. C. (2015). Obstetric outcomes of human Herpes virus-2 infection among pregnant women in Benin, Nigeria. Nigerian journal of clinical practice, 18(4): 453-461.
[19] Kim, I. D., Chang, H. S., & Hwang, K. J. (2012). Herpes simplex virus 2 infection rate and necessity of screening during pregnancy: a clinical and seroepidemiologic study. Yonsei medical journal, 53(2): 401-407.
[20] Mohammad E. Abdul Kareem and Yahya Jirjees Salman. (2014). Study of TORCH infections in women with Bad Obstetric History (BOH) in Kirkuk city. Int. J. Curr. Microbiol. App. Sci, 3(10): 700-709
[21] Findal, G., Helbig, A., Haugen, G., Jenum, P. A., & Stray-Pedersen, B. (2017). Management of suspected primary Toxoplasma gondii infection in pregnant women in Norway: twenty years of experience of amniocentesis in a low-prevalence population. BMC pregnancy and childbirth, 17(1): 127.
[22] Biswas, D., Borkakoty, B., Mahanta, J., Walia, K., Saikia, L., Akoijam, B. S., ... & Zomawia, E. (2011). Seroprevalence and risk factors of herpes simplex virus type-2 infection among pregnant women in Northeast India. BMC infectious diseases, 11(1): 325.